compound 8u [PMID: 31999451]   Click here for help

GtoPdb Ligand ID: 10682

Immunopharmacology Ligand
Compound class: Synthetic organic
Comment: Compound 8u is a novel small molecule that simultaneously inhibits the cancer targets indoleamine-2,3-dioxygenase 1 (IDO1) and signal transducer and activator of transcription 3 (STAT3) [1] which was designed to elicit multicomponent antitumour immunity. Inhibition of IDO1 acts to circumvent IDO1-induced immunosuppression in the tumour microenvironment and inhbition of STAT3 targets multiple oncogenic signalling pathways in both tumour and immune cells within the tumour microenvironment.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 4
Hydrogen bond donors 3
Rotatable bonds 9
Topological polar surface area 109.25
Molecular weight 471.18
XLogP 4.62
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES O/N=C/1\C=C(NC(C(=O)Nc2cc(OC)cc(c2)OC)Cc2ccccc2)C(=O)c2c1cccc2
Isomeric SMILES O/N=C/1\C=C(NC(C(=O)Nc2cc(OC)cc(c2)OC)Cc2ccccc2)C(=O)c2c1cccc2
InChI InChI=1S/C27H25N3O5/c1-34-19-13-18(14-20(15-19)35-2)28-27(32)25(12-17-8-4-3-5-9-17)29-24-16-23(30-33)21-10-6-7-11-22(21)26(24)31/h3-11,13-16,25,29,33H,12H2,1-2H3,(H,28,32)/b30-23+
InChI Key BTNMSAUAXSTYIU-JJKYIXSRSA-N
Immunopharmacology Comments
Compound 8u is a novel small molecule that was designed to elicit multicomponent antitumour immunity by simultaneously inhibiting IDO1 and STAT3 [1]. It simultaneously disables immune checkpoints and blocks STAT3-mediated (oncogenic and immunosuppressive) signalling pathways.